Used primarily in the pharmaceutical industry as an active pharmaceutical ingredient (API) in the development of medications targeting central nervous system disorders. It functions as a potent antagonist of certain neurotransmitter receptors, making it valuable in the treatment of psychiatric conditions such as schizophrenia and bipolar disorder. Its structure allows for high selectivity and binding affinity, which contributes to improved therapeutic efficacy and reduced side effects compared to older antipsychotic agents. Commonly formulated in tablet or injectable dosage forms for clinical use.